Akornの資産のリターン
Akornの資産のリターン は何ですか。
Akorn, Inc.の資産のリターン は-30.36%です。
資産のリターン の定義は何ですか。
資産のリターンは 、企業の資産が収益を生み出す際の収益性を示します。純利益を平均総資産で除して計算されます。
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
OTCのセクタHealth Careにおける資産のリターン の企業と比べるAkorn
Akornは何をしますか。
Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Akornと類似の資産のリターン
- AMAG Pharmaceuticalsの資産のリターン は-30.45%です。
- Jade Leaderの資産のリターン は-30.42%です。
- 48North Cannabisの資産のリターン は-30.41%です。
- Karuna Therapeutics Incの資産のリターン は-30.38%です。
- Poxel SAの資産のリターン は-30.38%です。
- Fertozの資産のリターン は-30.37%です。
- Akornの資産のリターン は-30.36%です。
- Shellron Capital Ltdの資産のリターン は-30.35%です。
- Huajun Internationalの資産のリターン は-30.34%です。
- Neptune Wellness Solutions Incの資産のリターン は-30.33%です。
- Kingsman Mineralsの資産のリターン は-30.28%です。
- Nuchevの資産のリターン は-30.28%です。
- Sundanceの資産のリターン は-30.25%です。